Antiprotozoals, Part 1: Coccidia, Toxoplasma and Balantidium

Antiprotozoals, Part 1: Coccidia, Toxoplasma and Balantidium

Protozoal Diseases and Treatments

Overview of Protozoal Diseases

  • The lecture is divided into three parts: diseases with good evidence for treatment, those with uncertain efficacy, and diseases lacking any treatment options.

Coccidiosis: A Major Concern

  • Coccidiosis is highlighted as a significant economic issue affecting various species including poultry, cattle, goats, sheep, dogs, and cats.
  • It primarily affects young or immunosuppressed animals such as puppies and kittens, leading to diarrhea that may contain blood clots but not grossly bloody feces.

Clinical Presentation and Life Cycle

  • Symptoms include diarrhea with minor blood flecks; severe forms can affect the central nervous system (CNS), though this is rare.
  • The life cycle involves replication in the host's tissues where damage occurs due to the release of merozoites.

Treatment Options for Coccidiosis

  • Two main categories of treatments are discussed: coccidiostats (preventive) and coccidiocides (for active disease). These terms often overlap in practice.
  • There are 316 FDA-approved coccidiostats available; however, many represent variations from different companies rather than unique compounds.

Specific Medications Mentioned

  • Sulfonamides like sulfadimethoxine (Albon) are commonly used for treating coccidiosis in puppies and kittens.
  • Amprolium (trade name Corid), a thiamine antagonist effective against coccidia, is administered orally through water solutions but may have taste acceptance issues.

Safety and Efficacy Considerations

  • Amprolium has a high therapeutic index making it safe even at high doses; however, caution is advised when using it in cats due to potential deficiencies.
  • Detoxifying agents like Decoquinate disrupt electron transport in coccidia and serve as an adjunct therapy for other protozoal diseases.

Toxoplasmosis and Its Implications

Overview of Toxoplasmosis

  • Toxoplasma gondii is a parasite with cats as the definitive host, but it can infect various species, including humans.
  • The tissue phase of T. gondii poses significant health risks, affecting multiple organs and leading to diverse clinical signs.

Health Risks Associated with Toxoplasmosis

  • Respiratory issues such as pneumonia and ocular complications like retinal injury are common manifestations.
  • Pregnant women living with cats should consider testing for toxoplasmosis; however, the risk is often overstated if proper precautions (like wearing gloves when handling litter) are taken.

Clinical Manifestations in Humans

  • Central nervous system (CNS) involvement can lead to severe conditions such as meningoencephalitis or myelitis.
  • Common treatments include pyrimethamine and sulfadiazine; clindamycin is also used due to its better tolerance in patients.

Zoonotic Nature of Toxoplasmosis

  • Dogs, cats, and humans can contract toxoplasmosis; it is considered zoonotic.
  • Large bowel diarrhea and dehydration are notable clinical signs observed in dogs related to whipworm infections.
Video description

by Dr. Vernon Langston, DVM, PhD, DACVCP Mississippi State University College of Veterinary Medicine Focuses upon therapy for coccidia, Toxoplasma, and Balantidium For additional videos and learning materials, please register with VetMedAcademy at https://vetmedacademy.org